PRIMARY FALLOPIAN TUBE CANCER: DIAGNOSIS AND TREATMENT RESULTS

D.G. Sumtsov; G.O. Sumtsov; N.I. Hyriavenko; S.A. Smiian; N.V. Kalashnyk; K.O. Sikora; N.M. Rozhkovska; I.Z. Gladchuk

doi:10.34921/amj.2023.4.011

Authors

D.G. Sumtsov Sumy Regional Clinical Oncological Dispensary
G.O. Sumtsov Sumy State University
N.I. Hyriavenko Sumy State University
S.A. Smiian Sumy State University
N.V. Kalashnyk Sumy State University
K.O. Sikora Sumy State University
N.M. Rozhkovska Odesa National Medical University
I.Z. Gladchuk Odesa National Medical University

DOI:

https://doi.org/10.34921/amj.2023.4.011

Keywords:

primary fallopian tubes cancer, diagnosis, treatment, prognosis

Abstract

A retrospective analysis was conducted on the material of the Sumy Regional Clinical Oncology Dispensary, involving 253 patients with primary fallopian tube cancer. The progression of diagnostic and treatment outcomes for primary fallopian tube cancer was presented over the period from 1964 to 2021. In the group of 163 patients from 1964 to 1995, the five-year survival rate was 56.9%, while among the 90 patients from 1995 to 2021, it increased to 67.2%. In 1996-2021, among patients who underwent adjuvant polychemotherapy according to modern protocols with platinum and taxane drugs, the five-year survival rate reached 84.2±5.9% (32/38) with a confidence interval of 69-94, including patients with stage I – 92.9±6.9% (13/14) with a confidence interval of 66-100.
Detailed assessment of clinical and morphological manifestations, and adequate use of modern complementary diagnostic methods and drugs can improve the recognition and treatment of primary fallopian tube cancer.